Source:http://linkedlifedata.com/resource/pubmed/id/17262087
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2007-3-5
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:status |
PubMed-not-MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1745-8382
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
132-3
|
pubmed:year |
2007
|
pubmed:articleTitle |
Should induction therapy with high-dose glucocorticoids be the standard treatment for all patients with giant cell arteritis?
|
pubmed:affiliation |
Center for Vasculitis Care and Research, Cleveland Clinic Foundation, Lerner College of Medicine, Cleveland, OH 44195, USA.
|
pubmed:publicationType |
Journal Article,
Comment
|